Corticosteroid Therapy for Severe Community-Acquired Pneumonia
Status:
Unknown status
Trial end date:
2017-05-01
Target enrollment:
Participant gender:
Summary
The purpose of the present study is to assess the efficacy of methylprednisolone as an
adjuvant therapy in patients with severe community-acquired pneumonia (CAP) (PSI 4-5).
The hypothesis of the study is that methylprednisolone can decrease the mortality of severe
CAP without any significant side effects,with reduction of the time to clinical stability and
failure rate of treatment.
Phase:
Phase 4
Details
Lead Sponsor:
Peking Union Medical College Hospital
Collaborators:
Affiliated Hospital of Hebei University Affiliated hospital of Taishan medical university Cangzhou Central Hospital Cangzhou People's Hospital First Affiliated Hospital of Wenzhou Medical University Jinhua Central Hospital Nantong University Navy general hospital PLA China Northern Jiangsu Province People's Hospital Taishan Medical University Affiliated Hospital The First Affiliated Hospital of Anhui Medical University The Second Hospital of Hebei Medical University Tianjin Medical University General Hospital Tianjin Third Central Hospital Zhejiang University